This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ose Immunotherapeutics. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Charlène Trilleaud
Introduction
Charlène Trilleaud is a notable inventor based in Rezé, France. She has made significant contributions to the field of immunotherapy, particularly through her work on humanized antibodies. Her innovative approach has the potential to impact therapeutic applications significantly.
Latest Patents
Charlène Trilleaud holds a patent for "Anti-Chemokine Like Receptor 1 Humanized Antibodies and Their Therapeutic Applications." This patent represents her commitment to advancing medical science and improving treatment options for various diseases.
Career Highlights
Charlène is currently employed at Ose Immunotherapeutics, a company dedicated to developing innovative immunotherapies. Her work at the company showcases her expertise and dedication to the field of biotechnology.
Collaborations
Charlène collaborates with Vanessa Gauttier, who is also a talented professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.
Conclusion
Charlène Trilleaud's contributions to immunotherapy through her patent and work at Ose Immunotherapeutics highlight her role as a key innovator in the field. Her efforts continue to pave the way for advancements in therapeutic applications.